Rosa Caputo

Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

Fortunato Ciardiello, Rosa Caputo, Roberto Bianco et al. · PubMed · 2001 · 646 citations

Medicine, Oncology, Pharmacology +17

Antitumor Activity of ZD6474, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Human Cancer Cells with Acquired Resistance to Antiepidermal Growth Factor Receptor Therapy

Fortunato Ciardiello, Roberto Bianco, Roberta Caputo et al. · Clinical Cancer Research · 2004 · 347 citations

Medicine, Oncology, Pharmacology +17

Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.

Fortunato Ciardiello, Rosa Caputo, Vincenzo Damiano et al. · PubMed · 2003 · 329 citations

Medicine, Oncology, Pharmacology +17

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

Cataldo Bianco, Giampaolo Tortora, Roberto Bianco et al. · PubMed · 2002 · 246 citations

Medicine, Oncology, Pharmacology +15

Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.

Giampaolo Tortora, Rosa Caputo, Vincenzo Damiano et al. · PubMed · 2003 · 148 citations

Medicine, Oncology, Pharmacology +15